Doctor profile · Federal record
Dr. Andrew Brunner, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Boston, MA
- NPI 1699095166
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
Massachusetts General Hospital, 55 Fruit St.
Boston, MA 02114
(617) 726-2000
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- April 6, 2016
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Massachusetts #252646 · Massachusetts #L-243818
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699095166. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
692
Distinct HCPCS
5
Medicare allowed
$87,395
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 274 | 56 | $126 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 230 | 63 | $104 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 146 | 50 | $153 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 22 | $184 | |
99239 |
Hospital discharge day management, more than 30 minutes | 19 | 19 | $123 |
In context: peer comparison
Among 64 peers in Boston Hematology & Oncology Physician, average services per provider: 129. This provider delivers 5.4× the peer median.Open Payments
Industry payments received
All-time total
$18,783
Transactions
29
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | 7 | $9,920.41 | |
| Servier Pharmaceuticals LLC | 6 | $5,837.72 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $1,211.00 | |
| Abbvie INC. | 1 | $675.00 | |
| AstraZeneca Pharmaceuticals Lp | 4 | $453.68 | |
| Taiho Oncology, INC. | 4 | $257.42 | |
| Daiichi Sankyo INC. | 2 | $233.26 | |
| Astellas Pharma US INC | 1 | $153.98 | |
| Celgene Corporation | 1 | $40.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
116
Patients
0
Total drug cost
$735,111
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Inqovi (Decitabine/Cedazuridine) | Brand | 36 | 0 | $305,244 |
| Acyclovir | Generic | 34 | 0 | $466 |
| Sprycel (Dasatinib) | Brand | 32 | 0 | $429,334 |
| Prochlorperazine Maleate | Generic | 14 | 0 | $67 |
Hospital affiliations
Frequently asked questions
What is Dr. Andrew Brunner's medical specialty?
Dr. Andrew Brunner practices Hematology & Oncology Physician in Boston, MA.
Where does Dr. Andrew Brunner practice?
Dr. Andrew Brunner practices at Massachusetts General Hospital, Boston, MA 02114. Office phone: 6177262000.
What is Dr. Andrew Brunner's NPI?
Dr. Andrew Brunner's National Provider Identifier (NPI) is 1699095166, issued by NPPES.
Does Dr. Andrew Brunner accept Medicare assignment?
Yes. Dr. Andrew Brunner accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Brunner commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.